Biotechnology
The Biotechnology industry has a total of 586 stocks, with a combined market cap of $1.1 trillion and total revenue of $110 billion.
Market Cap
1.1T
Revenue
110B
Profits
-41.21B
PE Ratio
n/a
Profit Margin
-37.46%
Dividend Yield
0.04%
586 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 113.14B | 0.63% | 871,093 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 62.69B | 0.79% | 1,190,399 | 14.92B |
| 3 | ARGX | argenx SE | 54.50B | 0.18% | 304,712 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.75B | 1.89% | 1,259,816 | 4.29B |
| 5 | RPRX | Royalty Pharma plc | 32.03B | 1.40% | 3,746,778 | 2.44B |
| 6 | RVMD | Revolution Medicines, Inc. | 31.79B | 0.71% | 2,766,460 | - |
| 7 | ONC | BeOne Medicines AG | 29.81B | -0.97% | 515,453 | 5.70B |
| 8 | BNTX | BioNTech SE | 21.87B | 1.17% | 1,173,252 | 3.23B |
| 9 | INSM | Insmed Incorporated | 21.47B | 5.17% | 4,240,876 | 819.56M |
| 10 | ROIV | Roivant Sciences Ltd. | 20.89B | 1.97% | 3,486,635 | 8.26M |
| 11 | INCY | Incyte Corporation | 20.62B | 2.57% | 2,318,919 | 5.36B |
| 12 | MRNA | Moderna, Inc. | 18.94B | 0.27% | 5,080,448 | 2.23B |
| 13 | GMAB | Genmab A/S | 15.29B | 1.21% | 1,329,445 | 3.90B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 14.38B | -1.23% | 727,833 | 4.44B |
| 15 | EXEL | Exelixis, Inc. | 13.32B | 2.42% | 1,774,297 | 2.38B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 13.26B | 0.46% | 1,836,953 | 579.96M |
| 17 | ASND | Ascendis Pharma A/S | 13.24B | 3.61% | 540,524 | 998.25M |
| 18 | AXSM | Axsome Therapeutics, Inc. | 12.64B | 4.47% | 917,883 | 708.24M |
| 19 | IONS | Ionis Pharmaceuticals, Inc. | 12.33B | 1.41% | 1,568,662 | 1.06B |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 11.19B | 2.40% | 2,767,317 | 3.24B |
| 21 | SMMT | Summit Therapeutics Inc. | 11.09B | 1.28% | 5,034,903 | - |
| 22 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.00B | 2.06% | 285,806 | 1.13B |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.33B | -0.72% | 1,415,234 | 622.01M |
| 24 | NUVL | Nuvalent, Inc. | 9.74B | 39.28% | 51,699,503 | - |
| 25 | CYTK | Cytokinetics, Incorporated | 9.29B | 0.81% | 2,492,667 | 105.82M |
| 26 | KRYS | Krystal Biotech, Inc. | 9.13B | 2.65% | 233,122 | 417.30M |
| 27 | TECH | Bio-Techne Corporation | 8.52B | 3.34% | 3,553,741 | 1.21B |
| 28 | HALO | Halozyme Therapeutics, Inc. | 8.48B | 1.06% | 1,317,198 | 1.51B |
| 29 | CORT | Corcept Therapeutics Incorporated | 8.32B | 5.67% | 1,010,542 | 769.10M |
| 30 | ABVX | ABIVAX Société Anonyme | 7.90B | 1.17% | 1,182,905 | 5.67M |
| 31 | IBRX | ImmunityBio, Inc. | 7.59B | 1.12% | 12,672,982 | 140.98M |
| 32 | PRAX | Praxis Precision Medicines, Inc. | 6.98B | -1.15% | 465,491 | 7.46M |
| 33 | PTGX | Protagonist Therapeutics, Inc. | 6.81B | 8.00% | 878,565 | 74.06M |
| 34 | PCVX | Vaxcyte, Inc. | 6.77B | 1.19% | 1,318,816 | - |
| 35 | SYRE | Spyre Therapeutics, Inc. | 6.64B | 6.17% | 1,592,938 | - |
| 36 | IMVT | Immunovant, Inc. | 6.49B | 2.63% | 1,699,785 | - |
| 37 | APGE | Apogee Therapeutics, Inc. | 6.37B | 2.42% | 643,804 | - |
| 38 | KYMR | Kymera Therapeutics, Inc. | 6.33B | 4.00% | 748,279 | 51.48M |
| 39 | LEGN | Legend Biotech Corporation | 6.22B | 6.25% | 2,578,911 | 1.14B |
| 40 | CNTA | Centessa Pharmaceuticals plc | 6.15B | 0.15% | 2,302,698 | 15.00M |
| 41 | TGTX | TG Therapeutics, Inc. | 6.15B | 5.91% | 2,587,686 | 700.35M |
| 42 | PTCT | PTC Therapeutics, Inc. | 6.11B | 3.97% | 1,873,808 | 827.11M |
| 43 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.02B | 2.25% | 626,164 | 217.17M |
| 44 | MIRM | Mirum Pharmaceuticals, Inc. | 5.82B | 2.02% | 694,228 | 569.61M |
| 45 | BLTE | Belite Bio, Inc | 5.56B | 1.28% | 203,234 | - |
| 46 | COGT | Cogent Biosciences, Inc. | 5.47B | 2.63% | 3,082,220 | - |
| 47 | SRRK | Scholar Rock Holding Corporation | 5.46B | 4.06% | 978,811 | - |
| 48 | XENE | Xenon Pharmaceuticals Inc. | 5.11B | 3.24% | 1,429,827 | 7.50M |
| 49 | CGON | CG Oncology, Inc. | 5.00B | 4.25% | 1,236,655 | 5.07M |
| 50 | CRSP | CRISPR Therapeutics AG | 4.97B | -0.23% | 1,461,779 | 4.10M |
| 51 | LGND | Ligand Pharmaceuticals Incorporated | 4.88B | 2.33% | 173,528 | 274.48M |
| 52 | CAI | Caris Life Sciences, Inc. | 4.79B | 5.08% | 3,534,150 | 907.29M |
| 53 | DNTH | Dianthus Therapeutics, Inc. | 4.62B | 4.12% | 954,686 | 1.34M |
| 54 | TNGX | Tango Therapeutics, Inc. | 4.57B | 2.04% | 7,198,158 | 56.99M |
| 55 | TVTX | Travere Therapeutics, Inc. | 4.52B | 3.16% | 2,621,918 | 536.20M |
| 56 | CELC | Celcuity Inc. | 4.52B | 5.90% | 1,374,398 | - |
| 57 | ERAS | Erasca, Inc. | 4.17B | 4.20% | 4,650,851 | - |
| 58 | ORKA | Oruka Therapeutics, Inc. | 4.04B | 4.48% | 1,566,517 | - |
| 59 | MANE | Veradermics, Incorporated | 4.01B | 6.19% | 494,338 | - |
| 60 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.84B | 0.19% | 1,350,156 | 596.96M |
| 61 | ACAD | ACADIA Pharmaceuticals Inc. | 3.74B | 0.65% | 1,104,650 | 1.10B |
| 62 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.69B | 4.45% | 884,725 | 18.07M |
| 63 | EWTX | Edgewise Therapeutics, Inc. | 3.66B | -2.24% | 1,354,133 | - |
| 64 | NAMS | NewAmsterdam Pharma Company N.V. | 3.55B | -1.84% | 1,114,351 | 22.57M |
| 65 | VKTX | Viking Therapeutics, Inc. | 3.39B | -0.03% | 2,252,098 | - |
| 66 | DNLI | Denali Therapeutics Inc. | 3.30B | 6.40% | 1,916,842 | - |
| 67 | TLX | Telix Pharmaceuticals Limited | 3.20B | 2.06% | 107,935 | 803.79M |
| 68 | RLAY | Relay Therapeutics, Inc. | 3.07B | 3.15% | 2,963,903 | 10.68M |
| 69 | BEAM | Beam Therapeutics Inc. | 3.03B | 2.32% | 1,571,804 | 164.01M |
| 70 | RCUS | Arcus Biosciences, Inc. | 2.97B | 1.37% | 1,160,527 | 236.00M |
| 71 | DYN | Dyne Therapeutics, Inc. | 2.96B | 6.60% | 1,701,206 | - |
| 72 | GPCR | Structure Therapeutics Inc. | 2.93B | 9.21% | 1,873,127 | - |
| 73 | ARQT | Arcutis Biotherapeutics, Inc. | 2.85B | 5.80% | 1,777,409 | 415.62M |
| 74 | TARS | Tarsus Pharmaceuticals, Inc. | 2.65B | 3.20% | 615,559 | 535.08M |
| 75 | IRON | Disc Medicine, Inc. | 2.61B | 3.86% | 590,177 | - |
| 76 | ALMS | Alumis Inc. | 2.55B | 5.37% | 1,414,873 | 8.40M |
| 77 | KLRA | Kailera Therapeutics, Inc. | 2.54B | -0.30% | 577,121 | - |
| 78 | DFTX | Definium Therapeutics, Inc. | 2.50B | -0.30% | 1,969,688 | - |
| 79 | IDYA | IDEAYA Biosciences, Inc. | 2.47B | -10.83% | 4,244,076 | 225.27M |
| 80 | CLDX | Celldex Therapeutics, Inc. | 2.32B | 3.64% | 616,942 | 865.00K |
| 81 | VERA | Vera Therapeutics, Inc. | 2.28B | 0.19% | 913,363 | - |
| 82 | RARE | Ultragenyx Pharmaceutical Inc. | 2.24B | 5.56% | 1,622,570 | 670.00M |
| 83 | PHVS | Pharvaris N.V. | 2.20B | 0.03% | 444,989 | - |
| 84 | ELVN | Enliven Therapeutics, Inc. | 2.20B | 7.37% | 1,834,737 | - |
| 85 | IMNM | Immunome, Inc. | 2.08B | -1.18% | 1,077,310 | 4.02M |
| 86 | AUPH | Aurinia Pharmaceuticals Inc. | 2.03B | 0.77% | 982,511 | 298.30M |
| 87 | MLYS | Mineralys Therapeutics, Inc. | 1.99B | 7.47% | 2,550,449 | - |
| 88 | HRMY | Harmony Biosciences Holdings, Inc. | 1.97B | 5.28% | 1,091,497 | 899.11M |
| 89 | KOD | Kodiak Sciences Inc. | 1.94B | 4.90% | 705,076 | - |
| 90 | TRVI | Trevi Therapeutics, Inc. | 1.93B | 0.63% | 1,318,599 | - |
| 91 | NKTR | Nektar Therapeutics | 1.90B | -0.69% | 1,173,331 | 55.63M |
| 92 | VCEL | Vericel Corporation | 1.89B | 3.27% | 628,276 | 292.09M |
| 93 | ADMA | ADMA Biologics, Inc. | 1.88B | 0.74% | 3,115,842 | 509.86M |
| 94 | ZLAB | Zai Lab Limited | 1.87B | 1.03% | 1,373,404 | 453.28M |
| 95 | MESO | Mesoblast Limited | 1.86B | 3.48% | 173,709 | 65.38M |
| 96 | OCUL | Ocular Therapeutix, Inc. | 1.85B | 3.80% | 2,426,937 | 52.04M |
| 97 | LKFT | Lakefront Biotherapeutics NV | 1.85B | 1.58% | 191,921 | 1.20B |
| 98 | STOK | Stoke Therapeutics, Inc. | 1.83B | 1.28% | 453,564 | 32.08M |
| 99 | VRDN | Viridian Therapeutics, Inc. | 1.80B | 3.69% | 1,174,918 | 70.92M |
| 100 | NTLA | Intellia Therapeutics, Inc. | 1.80B | -4.45% | 5,627,600 | 66.09M |
| 101 | IOVA | Iovance Biotherapeutics, Inc. | 1.73B | -3.00% | 11,270,614 | 285.61M |
| 102 | NUVB | Nuvation Bio Inc. | 1.72B | 2.71% | 9,714,459 | 143.05M |
| 103 | RAPP | Rapport Therapeutics, Inc. | 1.71B | -2.29% | 256,680 | 20.00M |
| 104 | RXRX | Recursion Pharmaceuticals, Inc. | 1.71B | -3.01% | 17,847,932 | 66.41M |
| 105 | ZYME | Zymeworks Inc. | 1.70B | -2.80% | 875,735 | 81.26M |
| 106 | GENB | Generate Biomedicines, Inc. | 1.69B | 3.21% | 615,476 | 30.30M |
| 107 | NBTX | Nanobiotix S.A. | 1.69B | -4.29% | 109,569 | 38.27M |
| 108 | SRPT | Sarepta Therapeutics, Inc. | 1.68B | 2.19% | 2,437,071 | 2.18B |
| 109 | AGIO | Agios Pharmaceuticals, Inc. | 1.68B | 2.79% | 1,290,568 | 66.05M |
| 110 | BHVN | Biohaven Ltd. | 1.67B | -0.27% | 3,772,644 | - |
| 111 | QURE | uniQure N.V. | 1.67B | -2.00% | 1,182,637 | 18.09M |
| 112 | INVA | Innoviva, Inc. | 1.66B | 0.94% | 738,501 | 420.69M |
| 113 | ABCL | AbCellera Biologics Inc. | 1.62B | -2.21% | 5,672,301 | 79.21M |
| 114 | NRIX | Nurix Therapeutics, Inc. | 1.62B | - | 6,665,202 | 71.78M |
| 115 | FTRE | Fortrea Holdings Inc. | 1.60B | 1.87% | 867,238 | 2.71B |
| 116 | SNDX | Syndax Pharmaceuticals, Inc. | 1.57B | 4.30% | 1,435,471 | 217.17M |
| 117 | AAPG | Ascentage Pharma Group International | 1.56B | -0.29% | 2,569 | 82.08M |
| 118 | TYRA | Tyra Biosciences, Inc. | 1.54B | -3.03% | 1,424,038 | - |
| 119 | TSHA | Taysha Gene Therapies, Inc. | 1.54B | -1.29% | 4,310,598 | 7.47M |
| 120 | SION | Sionna Therapeutics, Inc. | 1.52B | 0.54% | 320,199 | - |
| 121 | CAPR | Capricor Therapeutics, Inc. | 1.51B | -0.57% | 976,366 | 11.13M |
| 122 | ANAB | AnaptysBio, Inc. | 1.50B | 0.53% | 452,607 | 232.39M |
| 123 | PVLA | Palvella Therapeutics, Inc. | 1.50B | -0.84% | 362,291 | - |
| 124 | IMCR | Immunocore Holdings plc | 1.45B | 2.66% | 319,569 | 412.81M |
| 125 | KALV | KalVista Pharmaceuticals, Inc. | 1.44B | - | 1,537,918 | 114.48M |
| 126 | VIR | Vir Biotechnology, Inc. | 1.44B | 0.71% | 1,657,914 | 65.50M |
| 127 | SLS | SELLAS Life Sciences Group, Inc. | 1.43B | -3.76% | 6,924,794 | - |
| 128 | ATAI | AtaiBeckley Inc. | 1.43B | 2.10% | 5,405,296 | 3.49M |
| 129 | NVAX | Novavax, Inc. | 1.43B | 0.58% | 4,589,831 | 596.34M |
| 130 | AVBP | ArriVent BioPharma, Inc. | 1.42B | 0.16% | 360,102 | - |
| 131 | MBX | MBX Biosciences, Inc. | 1.42B | 3.00% | 324,316 | - |
| 132 | GLUE | Monte Rosa Therapeutics, Inc. | 1.40B | -2.29% | 832,821 | 42.95M |
| 133 | SEPN | Septerna, Inc. | 1.40B | 1.97% | 277,830 | 72.26M |
| 134 | GHRS | GH Research PLC | 1.40B | 1.14% | 270,661 | - |
| 135 | ARDX | Ardelyx, Inc. | 1.38B | 1.08% | 2,977,932 | 427.68M |
| 136 | URGN | UroGen Pharma Ltd. | 1.37B | 3.41% | 830,889 | 140.49M |
| 137 | BCAX | Bicara Therapeutics Inc. | 1.35B | 2.29% | 619,084 | - |
| 138 | MPLT | MapLight Therapeutics, Inc. | 1.33B | -0.64% | 251,905 | - |
| 139 | MAZE | Maze Therapeutics, Inc. | 1.32B | 1.48% | 679,457 | 20.00M |
| 140 | PGEN | Precigen, Inc. | 1.32B | 3.92% | 3,545,656 | 31.60M |
| 141 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.32B | 1.19% | 3,115,540 | 204.73M |
| 142 | MLTX | MoonLake Immunotherapeutics | 1.31B | -1.11% | 962,577 | - |
| 143 | INBX | Inhibrx Biosciences, Inc. | 1.31B | -0.03% | 248,144 | 1.30M |
| 144 | DMRA | Damora Therapeutics, Inc. | 1.29B | -0.12% | 462,125 | - |
| 145 | SVRA | Savara Inc. | 1.25B | -2.57% | 3,133,233 | - |
| 146 | IMTX | Immatics N.V. | 1.23B | -0.65% | 596,079 | 43.00M |
| 147 | AVLN | Avalyn Pharma Inc. | 1.20B | 2.17% | 200,671 | - |
| 148 | COAG | Hemab Therapeutics Holdings, Inc. | 1.19B | 5.68% | 182,467 | - |
| 149 | ZBIO | Zenas BioPharma, Inc. | 1.16B | 4.60% | 334,256 | 10.00M |
| 150 | WVE | Wave Life Sciences Ltd. | 1.11B | 1.40% | 3,802,366 | 71.80M |
| 151 | MNKD | MannKind Corporation | 1.10B | 5.31% | 4,907,647 | 360.78M |
| 152 | ABSI | Absci Corporation | 1.06B | 4.27% | 4,549,707 | 1.84M |
| 153 | AKTS | Aktis Oncology, Inc. | 1.05B | 0.42% | 129,814 | 8.28M |
| 154 | EYPT | EyePoint, Inc. | 986.81M | 2.79% | 1,874,484 | 7.61M |
| 155 | CRVS | Corvus Pharmaceuticals, Inc. | 939.29M | 0.18% | 1,624,198 | - |
| 156 | DBVT | DBV Technologies S.A. | 937.35M | 0.19% | 117,904 | 5.74M |
| 157 | SPTX | Seaport Therapeutics, Inc. | 936.47M | 9.01% | 148,386 | - |
| 158 | SPRY | ARS Pharmaceuticals, Inc. | 934.44M | 4.67% | 877,523 | 98.99M |
| 159 | OLMA | Olema Pharmaceuticals, Inc. | 912.78M | 4.92% | 1,008,867 | - |
| 160 | JBIO | Jade Biosciences, Inc. | 903.46M | 1.60% | 1,598,187 | - |
| 161 | PHAR | Pharming Group N.V. | 894.04M | -1.64% | 4,130 | 369.49M |
| 162 | XNCR | Xencor, Inc. | 881.54M | 4.21% | 1,009,031 | 97.36M |
| 163 | MGTX | MeiraGTx Holdings plc | 852.93M | 1.32% | 593,022 | 79.76M |
| 164 | ANNX | Annexon, Inc. | 851.98M | 1.56% | 3,194,947 | - |
| 165 | TBPH | Theravance Biopharma, Inc. | 850.11M | 1.23% | 332,098 | 109.78M |
| 166 | ABUS | Arbutus Biopharma Corporation | 839.54M | 0.24% | 1,072,407 | 191.45M |
| 167 | LBRX | LB Pharmaceuticals Inc | 839.37M | -0.14% | 362,817 | - |
| 168 | LXRX | Lexicon Pharmaceuticals, Inc. | 835.09M | - | 1,262,124 | 69.64M |
| 169 | JANX | Janux Therapeutics, Inc. | 830.61M | 1.11% | 507,643 | 13.73M |
| 170 | DRTS | Alpha Tau Medical Ltd. | 828.72M | -0.97% | 767,528 | - |
| 171 | ORIC | ORIC Pharmaceuticals, Inc. | 828.14M | 6.24% | 1,714,725 | - |
| 172 | ODTX | Odyssey Therapeutics, Inc. | 812.81M | 0.64% | 269,275 | 2.98M |
| 173 | CGEM | Cullinan Therapeutics, Inc. | 810.02M | -0.75% | 1,391,282 | - |
| 174 | ZVRA | Zevra Therapeutics, Inc. | 807.51M | 12.99% | 5,261,792 | 122.29M |
| 175 | SANA | Sana Biotechnology, Inc. | 784.78M | 4.83% | 8,760,909 | - |
| 176 | KURA | Kura Oncology, Inc. | 782.10M | 2.92% | 2,013,608 | 71.64M |
| 177 | IVA | Inventiva S.A. | 781.60M | 1.53% | 972,916 | 7.94M |
| 178 | PHAT | Phathom Pharmaceuticals, Inc. | 780.00M | -1.80% | 795,994 | 204.89M |
| 179 | REPL | Replimune Group, Inc. | 762.97M | 3.01% | 2,621,844 | - |
| 180 | ANRO | Alto Neuroscience, Inc. | 741.37M | 15.95% | 598,168 | - |
| 181 | EVMN | Evommune, Inc. | 738.02M | 1.49% | 379,027 | 10.00M |
| 182 | OMER | Omeros Corporation | 721.58M | 1.22% | 1,544,595 | 9.89M |
| 183 | VOR | Vor Biopharma Inc. | 719.59M | -0.08% | 867,772 | - |
| 184 | GERN | Geron Corporation | 718.50M | -0.88% | 13,609,087 | 196.12M |
| 185 | AURA | Aura Biosciences, Inc. | 700.40M | -2.01% | 647,518 | - |
| 186 | DRUG | Bright Minds Biosciences Inc. | 683.54M | 3.86% | 365,462 | - |
| 187 | CRMD | CorMedix Inc. | 678.61M | 1.29% | 1,412,758 | 400.05M |
| 188 | AVTX | Avalo Therapeutics, Inc. | 678.10M | 1.26% | 1,296,505 | 59.00K |
| 189 | OCS | Oculis Holding AG | 663.06M | 2.52% | 1,426,036 | 1.40M |
| 190 | DSGN | Design Therapeutics, Inc. | 658.92M | 0.86% | 466,540 | - |
| 191 | RLMD | Relmada Therapeutics, Inc. | 657.66M | 9.62% | 1,685,375 | - |
| 192 | CTMX | CytomX Therapeutics, Inc. | 648.75M | 1.36% | 4,595,834 | 35.54M |
| 193 | SLDB | Solid Biosciences Inc. | 646.81M | 2.50% | 957,614 | - |
| 194 | CADL | Candel Therapeutics, Inc. | 635.25M | 2.00% | 1,565,387 | - |
| 195 | TENX | Tenax Therapeutics, Inc. | 631.76M | 1.80% | 1,470,837 | - |
| 196 | ALLO | Allogene Therapeutics, Inc. | 628.18M | -1.62% | 7,723,871 | 22.00K |
| 197 | SGP | SpyGlass Pharma, Inc. | 608.03M | -2.93% | 70,064 | - |
| 198 | ACRS | Aclaris Therapeutics, Inc. | 600.55M | -1.38% | 1,022,628 | 8.37M |
| 199 | CBIO | Crescent Biopharma, Inc. | 598.12M | 4.17% | 126,141 | 11.88M |
| 200 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 581.58M | -6.68% | 526,212 | - |
| 201 | ACHV | Achieve Life Sciences, Inc. | 574.89M | 2.19% | 1,194,742 | - |
| 202 | RIGL | Rigel Pharmaceuticals, Inc. | 568.38M | 2.13% | 238,791 | 299.77M |
| 203 | GYRE | Gyre Therapeutics, Inc. | 560.11M | 1.32% | 92,636 | 117.05M |
| 204 | IMMX | Immix Biopharma, Inc. | 559.02M | 1.78% | 1,332,718 | - |
| 205 | TRAX | First Tracks Biotherapeutics, Inc. | 557.23M | 1.40% | 391,021 | - |
| 206 | MDXG | MiMedx Group, Inc. | 552.59M | 0.27% | 1,134,621 | 389.42M |
| 207 | DNA | Ginkgo Bioworks Holdings, Inc. | 538.93M | 1.98% | 1,102,712 | 151.40M |
| 208 | TECX | Tectonic Therapeutic, Inc. | 538.90M | -1.86% | 258,778 | - |
| 209 | CLYM | Climb Bio, Inc. | 531.90M | 3.39% | 3,678,580 | - |
| 210 | XOMA | XOMA Royalty Corporation | 526.10M | 0.07% | 94,914 | 48.56M |
| 211 | CABA | Cabaletta Bio, Inc. | 525.04M | 0.63% | 4,551,479 | - |
| 212 | PRME | Prime Medicine, Inc. | 520.18M | -2.70% | 2,358,522 | 4.03M |
| 213 | ALT | Altimmune, Inc. | 517.30M | -2.56% | 3,352,661 | 36.00K |
| 214 | PROK | ProKidney Corp. | 504.44M | -2.34% | 465,794 | 889.00K |
| 215 | VALN | Valneva SE | 499.00M | -0.47% | 14,809 | 180.25M |
| 216 | FDMT | 4D Molecular Therapeutics, Inc. | 482.51M | 6.83% | 609,081 | 88.24M |
| 217 | AGMB | AgomAb Therapeutics NV | 476.72M | -6.11% | 132,041 | - |
| 218 | KYTX | Kyverna Therapeutics, Inc. | 475.16M | 1.82% | 729,561 | - |
| 219 | EIKN | Eikon Therapeutics, Inc. | 474.80M | -2.34% | 204,985 | - |
| 220 | ARVN | Arvinas, Inc. | 465.20M | 0.84% | 981,343 | 89.40M |
| 221 | NGNE | Neurogene Inc. | 455.25M | 0.73% | 549,592 | 925.00K |
| 222 | OVID | Ovid Therapeutics Inc. | 451.67M | 2.54% | 1,483,630 | 7.12M |
| 223 | ASMB | Assembly Biosciences, Inc. | 449.65M | 0.58% | 243,770 | 71.10M |
| 224 | PRTA | Prothena Corporation plc | 443.43M | -1.05% | 493,462 | 57.94M |
| 225 | ANL | Adlai Nortye Ltd. | 433.60M | 5.96% | 171,094 | 5.00M |
| 226 | CTNM | Contineum Therapeutics, Inc. | 428.82M | -0.52% | 202,905 | - |
| 227 | STRO | Sutro Biopharma, Inc. | 427.35M | 1.50% | 158,760 | 99.61M |
| 228 | OCGN | Ocugen, Inc. | 419.77M | -1.59% | 4,580,021 | 4.47M |
| 229 | FBRX | Forte Biosciences, Inc. | 415.41M | 8.49% | 415,549 | - |
| 230 | RZLT | Rezolute, Inc. | 407.42M | -4.41% | 2,371,572 | - |
| 231 | EDIT | Editas Medicine, Inc. | 406.67M | 0.19% | 1,877,577 | 38.69M |
| 232 | MNPR | Monopar Therapeutics Inc. | 402.66M | -0.82% | 167,459 | - |
| 233 | SGMT | Sagimet Biosciences Inc. | 402.62M | -0.15% | 689,826 | - |
| 234 | IPSC | Century Therapeutics, Inc. | 398.58M | 4.25% | 837,044 | 109.16M |
| 235 | CCCC | C4 Therapeutics, Inc. | 394.45M | -0.28% | 1,649,212 | 34.86M |
| 236 | VTVT | vTv Therapeutics Inc. | 394.25M | -0.90% | 12,727 | 36.84M |
| 237 | PRLD | Prelude Therapeutics Incorporated | 390.76M | 2.60% | 235,360 | 16.72M |
| 238 | EPRX | Eupraxia Pharmaceuticals Inc. | 390.48M | -0.33% | 451,972 | - |
| 239 | AUTL | Autolus Therapeutics plc | 388.57M | - | 1,567,398 | 92.62M |
| 240 | BNTC | Benitec Biopharma Inc. | 372.06M | 3.14% | 92,143 | - |
| 241 | CMPX | Compass Therapeutics, Inc. | 370.98M | 1.98% | 2,327,289 | 850.00K |
| 242 | VNDA | Vanda Pharmaceuticals Inc. | 368.03M | 3.03% | 825,677 | 217.78M |
| 243 | LRMR | Larimar Therapeutics, Inc. | 365.34M | 12.90% | 3,067,849 | - |
| 244 | XFOR | X4 Pharmaceuticals, Inc. | 364.55M | 4.18% | 434,522 | 9.01M |
| 245 | UPB | Upstream Bio, Inc. | 364.07M | 3.72% | 500,520 | 3.32M |
| 246 | PBYI | Puma Biotechnology, Inc. | 358.84M | 3.07% | 169,422 | 227.18M |
| 247 | ARTV | Artiva Biotherapeutics, Inc. | 353.24M | 6.91% | 997,762 | 251.00K |
| 248 | CNXU | Conexeu Sciences Inc. | 352.26M | -8.71% | 84,120 | - |
| 249 | ZURA | Zura Bio Limited | 350.11M | 4.53% | 584,615 | - |
| 250 | AVIR | Atea Pharmaceuticals, Inc. | 348.92M | 0.93% | 233,264 | - |
| 251 | OABI | OmniAb, Inc. | 347.93M | 5.26% | 387,299 | 28.94M |
| 252 | VSTM | Verastem, Inc. | 335.68M | 4.09% | 3,069,613 | 49.59M |
| 253 | LXEO | Lexeo Therapeutics, Inc. | 332.93M | 0.71% | 437,809 | - |
| 254 | ENTA | Enanta Pharmaceuticals, Inc. | 330.62M | 2.71% | 131,333 | 69.21M |
| 255 | RGNX | REGENXBIO Inc. | 327.76M | 3.43% | 1,986,932 | 87.82M |
| 256 | STTK | Shattuck Labs, Inc. | 327.43M | 9.49% | 1,461,700 | 1.00M |
| 257 | GLSI | Greenwich LifeSciences, Inc. | 326.30M | 2.68% | 86,132 | - |
| 258 | ABEO | Abeona Therapeutics Inc. | 310.62M | 1.30% | 1,159,224 | 14.54M |
| 259 | HUMA | Humacyte, Inc. | 308.61M | 0.72% | 4,746,744 | 2.02M |
| 260 | FENC | Fennec Pharmaceuticals Inc. | 304.64M | -1.46% | 149,275 | 51.00M |
| 261 | LCTX | Lineage Cell Therapeutics, Inc. | 304.14M | 0.83% | 1,396,011 | 14.78M |
| 262 | NMRA | Neumora Therapeutics, Inc. | 301.44M | 1.85% | 785,081 | - |
| 263 | NAUT | Nautilus Biotechnology, Inc. | 298.64M | 0.86% | 352,249 | - |
| 264 | LYEL | Lyell Immunopharma, Inc. | 296.34M | 3.17% | 99,177 | 31.00K |
| 265 | DMAC | DiaMedica Therapeutics Inc. | 292.05M | -3.39% | 351,393 | - |
| 266 | IVVD | Invivyd, Inc. | 291.66M | -2.94% | 5,413,425 | 55.87M |
| 267 | IRD | Opus Genetics, Inc. | 291.32M | 1.24% | 803,671 | 11.98M |
| 268 | BCYC | Bicycle Therapeutics plc | 291.11M | 1.46% | 673,323 | 63.50M |
| 269 | RCKT | Rocket Pharmaceuticals, Inc. | 289.36M | -1.85% | 2,717,073 | - |
| 270 | ARMP | Armata Pharmaceuticals, Inc. | 285.49M | 2.77% | 120,789 | 5.20M |
| 271 | IKT | Inhibikase Therapeutics, Inc. | 284.61M | 3.09% | 792,922 | 1.00 |
| 272 | SLN | Silence Therapeutics plc | 283.88M | -3.53% | 183,390 | 839.00K |
| 273 | PALI | Palisade Bio, Inc. | 282.95M | -2.87% | 1,704,370 | - |
| 274 | NAGE | Niagen Bioscience, Inc. | 280.14M | 4.15% | 784,621 | 130.42M |
| 275 | ELDN | Eledon Pharmaceuticals, Inc. | 274.42M | -0.84% | 1,217,535 | - |
| 276 | ELTX | Elicio Therapeutics, Inc. | 261.22M | 4.80% | 127,121 | - |
| 277 | IMRX | Immuneering Corporation | 260.73M | 2.54% | 1,382,440 | - |
| 278 | NVCT | Nuvectis Pharma, Inc. | 259.95M | 4.03% | 64,124 | - |
| 279 | ZNTL | Zentalis Pharmaceuticals, Inc. | 254.85M | - | 442,905 | 26.87M |
| 280 | SRZN | Surrozen, Inc. | 252.87M | 5.27% | 82,284 | 7.49M |
| 281 | SLGL | Sol-Gel Technologies Ltd. | 249.16M | -4.73% | 42,602 | 18.47M |
| 282 | MGNX | MacroGenics, Inc. | 248.52M | 0.77% | 532,401 | 157.08M |
| 283 | IFRX | InflaRx N.V. | 244.51M | -2.92% | 2,133,292 | 33.82K |
| 284 | OBIO | Orchestra BioMed Holdings, Inc. | 241.32M | 2.03% | 187,789 | 32.72M |
| 285 | SABS | SAB Biotherapeutics, Inc. | 236.13M | -1.18% | 362,645 | 114.70K |
| 286 | AVXL | Anavex Life Sciences Corp. | 235.39M | -3.05% | 868,970 | - |
| 287 | FULC | Fulcrum Therapeutics, Inc. | 234.55M | 2.33% | 3,984,925 | 80.00M |
| 288 | TRDA | Entrada Therapeutics, Inc. | 229.53M | 1.76% | 175,795 | 5.74M |
| 289 | INDP | Indaptus Therapeutics, Inc. | 229.32M | -3.57% | 1,585,576 | - |
| 290 | FHTX | Foghorn Therapeutics Inc. | 227.22M | 4.31% | 138,203 | 28.22M |
| 291 | ADAG | Adagene Inc. | 224.65M | 4.29% | 102,860 | 7.67M |
| 292 | CDXS | Codexis, Inc. | 224.51M | -5.18% | 1,054,117 | 78.09M |
| 293 | ACIU | AC Immune SA | 224.19M | 3.20% | 575,646 | 4.62M |
| 294 | TARA | Protara Therapeutics, Inc. | 223.13M | -1.73% | 982,578 | - |
| 295 | FATE | Fate Therapeutics, Inc. | 221.46M | -0.52% | 1,888,756 | 6.32M |
| 296 | NERV | Minerva Neurosciences, Inc. | 220.83M | 3.24% | 96,309 | - |
| 297 | CHRS | Coherus Oncology, Inc. | 219.03M | 0.35% | 691,496 | 46.88M |
| 298 | LENZ | LENZ Therapeutics, Inc. | 212.90M | 1.04% | 374,830 | 20.99M |
| 299 | CLLS | Cellectis S.A. | 210.84M | 2.05% | 41,937 | 75.11M |
| 300 | CAMP | Camp4 Therapeutics Corporation | 210.04M | -1.10% | 60,027 | 3.93M |
| 301 | WHWK | Whitehawk Therapeutics, Inc. | 208.69M | 4.98% | 362,312 | 7.15M |
| 302 | ALXO | ALX Oncology Holdings Inc. | 208.57M | -1.27% | 502,044 | - |
| 303 | VYGR | Voyager Therapeutics, Inc. | 207.25M | 1.78% | 488,236 | 36.49M |
| 304 | YDES | YD Bio Limited | 206.74M | -1.01% | 10,318 | 510.36K |
| 305 | ARCT | Arcturus Therapeutics Holdings Inc. | 203.51M | 0.56% | 242,351 | 54.71M |
| 306 | QTTB | Q32 Bio Inc. | 201.61M | -1.16% | 628,565 | 53.74M |
| 307 | RNAC | Cartesian Therapeutics, Inc. | 201.26M | 16.89% | 3,494,442 | 1.78M |
| 308 | RNA | Atrium Therapeutics, Inc. | 201.16M | 1.82% | 201,685 | 36.68M |
| 309 | KROS | Keros Therapeutics, Inc. | 199.30M | 0.70% | 196,823 | 33.18M |
| 310 | HELP | Cybin Inc. | 196.14M | -2.24% | 816,180 | - |
| 311 | KPTI | Karyopharm Therapeutics Inc. | 195.97M | 2.24% | 324,139 | 151.12M |
| 312 | UNCY | Unicycive Therapeutics, Inc. | 194.11M | 9.16% | 874,071 | - |
| 313 | NGEN | NervGen Pharma Corp. | 192.23M | -0.55% | 617,037 | - |
| 314 | CGEN | Compugen Ltd. | 190.59M | -1.23% | 462,765 | 72.66M |
| 315 | NBP | NovaBridge Biosciences | 183.88M | 1.92% | 402,121 | - |
| 316 | MDWD | MediWound Ltd. | 183.79M | 0.63% | 91,996 | 14.48M |
| 317 | TNXP | Tonix Pharmaceuticals Holding Corp. | 182.68M | -2.13% | 547,004 | 17.56M |
| 318 | CRBU | Caribou Biosciences, Inc. | 182.49M | - | 1,632,091 | 11.20M |
| 319 | ALEC | Alector, Inc. | 180.97M | -0.61% | 439,473 | 18.42M |
| 320 | DTIL | Precision BioSciences, Inc. | 177.00M | 1.33% | 558,662 | 45.07M |
| 321 | NKTX | Nkarta, Inc. | 175.29M | 2.08% | 479,492 | - |
| 322 | OKUR | OnKure Therapeutics, Inc. | 171.68M | -3.41% | 176,991 | - |
| 323 | EQ | Equillium, Inc. | 170.71M | -2.53% | 436,246 | 4.39M |
| 324 | IPHA | Innate Pharma S.A. | 167.05M | 1.67% | 1,755 | 10.57M |
| 325 | IMUX | Immunic, Inc. | 167.00M | 1.66% | 254,579 | - |
| 326 | ENLV | Enlivex Ltd. | 166.95M | -3.02% | 355,537 | - |
| 327 | MIST | Milestone Pharmaceuticals Inc. | 164.62M | -1.63% | 812,853 | 1.78M |
| 328 | PLX | Protalix BioTherapeutics, Inc. | 159.53M | 1.02% | 460,545 | 76.38M |
| 329 | GALT | Galectin Therapeutics Inc. | 158.72M | 0.42% | 294,924 | - |
| 330 | TLSA | Tiziana Life Sciences Ltd | 158.40M | 0.41% | 132,551 | - |
| 331 | ABOS | Acumen Pharmaceuticals, Inc. | 158.18M | 0.92% | 316,387 | - |
| 332 | KRRO | Korro Bio, Inc. | 157.78M | 3.31% | 116,101 | 3.84M |
| 333 | PRQR | ProQR Therapeutics N.V. | 154.88M | -3.92% | 476,826 | 15.73M |
| 334 | TNYA | Tenaya Therapeutics, Inc. | 154.07M | 3.44% | 2,786,277 | 225.00K |
| 335 | CNTN | Canton Strategic Holdings, Inc. | 151.84M | 1.13% | 994,416 | - |
| 336 | TTRX | Turn Therapeutics Inc. | 150.58M | -5.16% | 43,707 | - |
| 337 | ORMP | Oramed Pharmaceuticals Inc. | 149.38M | 0.27% | 217,209 | 2.00M |
| 338 | SPRO | Spero Therapeutics, Inc. | 148.81M | -6.20% | 1,129,124 | 61.19M |
| 339 | MOLN | Molecular Partners AG | 143.54M | -1.77% | 2,306 | 856.30K |
| 340 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 142.66M | 1.85% | 293,731 | - |
| 341 | ANTX | AN2 Therapeutics, Inc. | 140.74M | 1.56% | 167,024 | - |
| 342 | NRXP | NRx Pharmaceuticals, Inc. | 140.08M | -10.62% | 2,703,798 | 2.29M |
| 343 | ADCT | ADC Therapeutics SA | 139.91M | 12.51% | 8,628,894 | 79.18M |
| 344 | CNTX | Context Therapeutics Inc. | 139.66M | -11.11% | 846,569 | - |
| 345 | SPRB | Spruce Biosciences, Inc. | 134.94M | -0.59% | 42,610 | 697.00K |
| 346 | MENS | Jyong Biotech Ltd. | 134.36M | -9.50% | 105,151 | - |
| 347 | CNTB | Connect Biopharma Holdings Limited | 133.48M | -3.64% | 339,488 | 233.00K |
| 348 | GNLX | Genelux Corporation | 132.34M | 1.54% | 94,587 | 8.00K |
| 349 | KZIA | Kazia Therapeutics Limited | 131.41M | 0.88% | 81,848 | 1.27M |
| 350 | ACOG | Alpha Cognition Inc. | 130.64M | -0.33% | 92,194 | 10.83M |
| 351 | AGEN | Agenus Inc. | 129.18M | -0.96% | 499,225 | 123.87M |
| 352 | HURA | TuHURA Biosciences, Inc. | 128.64M | -1.22% | 390,863 | - |
| 353 | ALPS | Alps Group Inc | 117.31M | -1.74% | 9,821 | 3.74M |
| 354 | NTHI | NeOnc Technologies Holdings, Inc. | 112.91M | -0.67% | 27,299 | 39.99K |
| 355 | ENGN | enGene Therapeutics Inc. | 111.87M | 1.21% | 495,081 | - |
| 356 | BDTX | Black Diamond Therapeutics, Inc. | 108.87M | 2.70% | 1,719,949 | 70.00M |
| 357 | PLYX | Polaryx Therapeutics, Inc. | 107.94M | -7.32% | 370,516 | - |
| 358 | PYXS | Pyxis Oncology, Inc. | 107.70M | 0.59% | 177,745 | 13.86M |
| 359 | GUTS | Fractyl Health, Inc. | 105.36M | -0.88% | 1,211,723 | 3.00K |
| 360 | VRCA | Verrica Pharmaceuticals Inc. | 105.13M | 2.17% | 33,040 | 37.16M |
| 361 | COYA | Coya Therapeutics, Inc. | 105.09M | -1.54% | 93,052 | 7.94M |
| 362 | CRDF | Cardiff Oncology, Inc. | 104.61M | 2.00% | 1,363,509 | 525.00K |
| 363 | ALDX | Aldeyra Therapeutics, Inc. | 103.75M | -1.15% | 961,287 | - |
| 364 | CGTX | Cognition Therapeutics, Inc. | 102.76M | -4.96% | 691,814 | - |
| 365 | CUE | Cue Biopharma, Inc. | 99.09M | 4.68% | 47,749 | 32.73M |
| 366 | VANI | Vivani Medical, Inc. | 98.31M | -0.87% | 145,122 | - |
| 367 | FBIO | Fortress Biotech, Inc. | 97.33M | 2.81% | 404,932 | 66.16M |
| 368 | KLRS | Kalaris Therapeutics, Inc. | 97.19M | -2.04% | 103,686 | - |
| 369 | PEPG | PepGen Inc. | 95.45M | 2.22% | 1,051,818 | - |
| 370 | ONCY | Oncolytics Biotech Inc. | 94.06M | -3.57% | 2,056,742 | - |
| 371 | PTHS | Pelthos Therapeutics Inc. | 93.49M | 2.28% | 815 | 27.70M |
| 372 | CBUS | Cibus, Inc. | 93.07M | -0.81% | 263,438 | 3.64M |
| 373 | SEER | Seer, Inc. | 92.92M | -5.59% | 436,757 | 15.17M |
| 374 | INO | Inovio Pharmaceuticals, Inc. | 90.13M | 0.92% | 1,158,366 | 65.34K |
| 375 | ICCC | ImmuCell Corporation | 88.39M | 0.72% | 17,998 | 29.93M |
| 376 | PYPD | PolyPid Ltd. | 87.63M | -1.08% | 69,051 | - |
| 377 | PMN | ProMIS Neurosciences, Inc. | 87.39M | 0.36% | 11,340 | - |
| 378 | RNTX | Rein Therapeutics Inc. | 85.63M | -2.98% | 391,973 | - |
| 379 | OTLK | Outlook Therapeutics, Inc. | 85.17M | -2.40% | 7,587,249 | 333.14K |
| 380 | RLYB | Rallybio Corporation | 84.16M | - | 24,182 | 858.00K |
| 381 | ATRA | Atara Biotherapeutics, Inc. | 83.16M | 1.98% | 65,948 | 23.14M |
| 382 | HYFT | MindWalk Holdings Corp. | 82.45M | 3.75% | 458,614 | 20.70M |
| 383 | BMEA | Biomea Fusion, Inc. | 82.06M | -1.30% | 1,017,881 | - |
| 384 | RANI | Rani Therapeutics Holdings, Inc. | 80.97M | -3.38% | 1,231,647 | 3.17M |
| 385 | OKYO | OKYO Pharma Limited | 80.82M | -3.14% | 41,535 | - |
| 386 | ANIX | Anixa Biosciences, Inc. | 80.47M | -2.44% | 108,335 | - |
| 387 | CSBR | Champions Oncology, Inc. | 80.40M | 2.66% | 5,798 | 57.95M |
| 388 | LIXT | Lixte Biotechnology Holdings, Inc. | 79.82M | 3.31% | 254,613 | - |
| 389 | LONA | LeonaBio, Inc. | 79.47M | -1.51% | 20,558 | - |
| 390 | MAIA | MAIA Biotechnology, Inc. | 79.04M | 2.36% | 612,388 | - |
| 391 | NRXS | NeurAxis, Inc. | 78.24M | 1.95% | 130,452 | 4.28M |
| 392 | AARD | Aardvark Therapeutics, Inc. | 78.10M | -0.28% | 111,385 | - |
| 393 | OSTX | OS Therapies Incorporated | 77.50M | -2.79% | 365,741 | - |
| 394 | ACET | Adicet Bio, Inc. | 76.76M | 1.25% | 54,641 | - |
| 395 | HRTX | Heron Therapeutics, Inc. | 76.64M | -10.74% | 4,387,509 | 150.71M |
| 396 | ANVS | Annovis Bio, Inc. | 75.30M | -1.12% | 1,196,304 | - |
| 397 | PLRX | Pliant Therapeutics, Inc. | 73.69M | 3.48% | 279,741 | - |
| 398 | XBIT | XBiotech Inc. | 72.26M | - | 10,021 | - |
| 399 | BYSI | BeyondSpring Inc. | 71.96M | 2.94% | 16,588 | 1.88M |
| 400 | ATHE | Alterity Therapeutics Limited | 71.19M | 9.44% | 1,600,386 | 4.43M |
| 401 | GANX | Gain Therapeutics, Inc. | 70.38M | -2.37% | 1,305,633 | - |
| 402 | FLNA | Filana Therapeutics, Inc. | 68.60M | -0.70% | 359,078 | - |
| 403 | EXOZ | eXoZymes, Inc. | 66.14M | -9.51% | 9,098 | -700.00 |
| 404 | TCRX | TScan Therapeutics, Inc. | 63.10M | -2.86% | 326,807 | 9.14M |
| 405 | IMA | ImageneBio, Inc. | 62.60M | -0.71% | 6,336 | 800.00K |
| 406 | MNOV | MediciNova, Inc. | 62.51M | -2.31% | 15,445 | 596.64K |
| 407 | IBO | Impact BioMedical Inc. | 62.17M | 3.02% | 288,600 | 39.00K |
| 408 | CING | Cingulate Inc. | 61.73M | 2.65% | 422,988 | - |
| 409 | IBIO | iBio, Inc. | 61.44M | -1.73% | 409,991 | 300.00K |
| 410 | MCRB | Seres Therapeutics, Inc. | 61.30M | 0.80% | 83,563 | 1.15M |
| 411 | ACRV | Acrivon Therapeutics, Inc. | 60.78M | 0.71% | 246,799 | - |
| 412 | ENTX | Entera Bio Ltd. | 60.05M | 1.67% | 25,135 | 42.00K |
| 413 | INKT | MiNK Therapeutics, Inc. | 58.89M | 4.23% | 28,955 | - |
| 414 | PDSB | PDS Biotechnology Corporation | 57.49M | 3.00% | 922,301 | - |
| 415 | PMVP | PMV Pharmaceuticals, Inc. | 56.00M | -3.67% | 226,515 | - |
| 416 | TIL | Instil Bio, Inc. | 54.39M | -0.74% | 16,178 | - |
| 417 | VERU | Veru Inc. | 49.76M | 3.33% | 2,367,395 | 16.89M |
| 418 | ESLA | Estrella Immunopharma, Inc. | 49.49M | 1.77% | 40,330 | - |
| 419 | MREO | Mereo BioPharma Group plc | 48.79M | 0.23% | 1,435,417 | 500.00K |
| 420 | IMMP | Immutep Limited | 48.75M | - | 513,581 | 5.28M |
| 421 | LTRN | Lantern Pharma Inc. | 48.61M | 1.60% | 287,658 | - |
| 422 | DWTX | Dogwood Therapeutics, Inc. | 48.43M | -0.68% | 40,491 | - |
| 423 | ACTU | Actuate Therapeutics, Inc. | 48.09M | 10.44% | 282,279 | - |
| 424 | RADX | Radiopharm Theranostics Limited | 47.55M | 0.95% | 16,936 | 10.86M |
| 425 | XLO | Xilio Therapeutics, Inc. | 46.31M | 0.78% | 37,417 | 53.48M |
| 426 | MGX | Metagenomi Therapeutics, Inc. | 46.31M | -4.65% | 174,004 | 22.33M |
| 427 | TVGN | Tevogen Bio Holdings Inc. | 45.02M | -7.65% | 33,416 | - |
| 428 | ATYR | aTyr Pharma, Inc. | 44.67M | 3.05% | 1,776,923 | 190.00K |
| 429 | EDSA | Edesa Biotech, Inc. | 43.90M | -8.01% | 297,677 | - |
| 430 | KALA | KALA BIO, Inc. | 43.69M | 2.62% | 84,424 | - |
| 431 | NTRB | Nutriband Inc. | 42.91M | - | 4,428 | 2.04M |
| 432 | GRDX | GridAI Technologies Corp. | 42.38M | 2.41% | 84,713 | - |
| 433 | TELO | Telomir Pharmaceuticals, Inc. | 41.60M | -5.47% | 52,860 | - |
| 434 | RNXT | RenovoRx, Inc. | 38.79M | -2.89% | 166,560 | 1.49M |
| 435 | ATOS | Atossa Therapeutics, Inc. | 37.98M | -3.08% | 53,866 | - |
| 436 | PSTV | Plus Therapeutics, Inc. | 37.86M | -0.54% | 108,412 | 5.18M |
| 437 | GNTA | Genenta Science S.p.A. | 37.75M | -11.11% | 460,542 | - |
| 438 | GOSS | Gossamer Bio, Inc. | 37.55M | -3.38% | 13,174,759 | 55.54M |
| 439 | HYPD | Hyperion DeFi, Inc. | 36.79M | -11.60% | 784,983 | 1.04M |
| 440 | GRCE | Grace Therapeutics, Inc. | 36.05M | 1.30% | 151,683 | - |
| 441 | ABVC | ABVC BioPharma, Inc. | 33.36M | -1.49% | 128,388 | 797.92K |
| 442 | INMB | INmune Bio Inc. | 32.43M | -1.61% | 262,683 | 50.00K |
| 443 | NNVC | NanoViricides, Inc. | 31.89M | -2.10% | 282,362 | - |
| 444 | ALGS | Aligos Therapeutics, Inc. | 31.81M | 3.63% | 81,239 | 4.71M |
| 445 | ATNM | Actinium Pharmaceuticals, Inc. | 31.49M | -4.72% | 136,934 | 90.00K |
| 446 | APLM | Apollomics, Inc. | 31.40M | 2.14% | 26,024 | 8.84M |
| 447 | BOLD | Boundless Bio, Inc. | 31.38M | -2.10% | 116,497 | - |
| 448 | LSTA | Lisata Therapeutics, Inc. | 31.16M | -0.86% | 91,439 | 170.00K |
| 449 | EVAX | Evaxion A/S | 30.19M | -2.95% | 28,300 | 7.53M |
| 450 | BRNS | Barinthus Biotherapeutics plc | 29.57M | 0.56% | 103,900 | 14.97M |
| 451 | DARE | Daré Bioscience, Inc. | 28.76M | 3.78% | 117,920 | 1.16M |
| 452 | SNTI | Senti Biosciences Holdings, Inc. | 28.21M | -3.81% | 178,419 | 38.00K |
| 453 | IGC | IGC Pharma, Inc. | 28.16M | -4.68% | 1,308,653 | 1.11M |
| 454 | KYNB | Kyntra Bio, Inc. | 27.08M | 0.90% | 19,448 | 7.44M |
| 455 | NRSN | NeuroSense Therapeutics Ltd. | 26.87M | 1.12% | 145,406 | - |
| 456 | CRVO | CervoMed Inc. | 26.76M | -0.69% | 30,636 | 2.09M |
| 457 | SKYE | Skye Bioscience, Inc. | 26.38M | -2.48% | 203,374 | - |
| 458 | BCTX | BriaCell Therapeutics Corp. | 26.37M | -0.65% | 301,625 | - |
| 459 | SER | Serina Therapeutics, Inc. | 26.37M | -6.84% | 85,620 | 130.00K |
| 460 | TVRD | Tvardi Therapeutics, Inc. | 26.08M | -2.46% | 67,875 | - |
| 461 | QNTM | Quantum BioPharma Ltd. | 25.78M | -3.95% | 321,833 | - |
| 462 | LITS | Lite Strategy, Inc. | 25.73M | 0.19% | 467,270 | - |
| 463 | PLUR | Pluri Inc. | 25.68M | 3.03% | 6,589 | 1.08M |
| 464 | NEUP | Neuphoria Therapeutics Inc. | 25.19M | -0.21% | 52,704 | -13.27K |
| 465 | PTN | Palatin Technologies, Inc. | 24.91M | 0.57% | 4,450 | 12.88M |
| 466 | ALLR | Allarity Therapeutics, Inc. | 24.89M | 1.90% | 171,228 | 345.00K |
| 467 | DYAI | Dyadic International, Inc. | 24.61M | -3.38% | 142,855 | 3.81M |
| 468 | LGVN | Longeveron Inc. | 24.07M | 2.48% | 120,135 | 1.22M |
| 469 | MRKR | Marker Therapeutics, Inc. | 23.76M | -2.40% | 27,304 | 3.55M |
| 470 | PLRZ | Polyrizon Ltd. | 22.54M | -3.83% | 3,047 | - |
| 471 | VYNE | VYNE Therapeutics Inc. | 21.70M | -1.15% | 76,946 | 454.00K |
| 472 | VTGN | Vistagen Therapeutics, Inc. | 21.31M | 0.11% | 477,811 | 789.00K |
| 473 | CELU | Celularity Inc. | 19.93M | -15.21% | 184,601 | 26.55M |
| 474 | TRAW | Traws Pharma, Inc. | 19.85M | -4.38% | 295,721 | 2.73M |
| 475 | KTTA | Pasithea Therapeutics Corp. | 19.38M | 0.76% | 310,135 | - |
| 476 | CLRB | Cellectar Biosciences, Inc. | 18.86M | -5.98% | 192,694 | - |
| 477 | AEON | AEON Biopharma, Inc. | 18.85M | -1.78% | 58,080 | - |
| 478 | CVM | CEL-SCI Corporation | 18.84M | -5.80% | 239,754 | - |
| 479 | TPST | Tempest Therapeutics, Inc. | 18.22M | - | 72,461 | - |
| 480 | HOWL | Werewolf Therapeutics, Inc. | 18.20M | -1.94% | 1,125,730 | 1.14M |
| 481 | XCUR | Exicure, Inc. | 18.17M | -4.68% | 27,346 | 500.00K |
| 482 | CRIS | Curis, Inc. | 17.87M | -4.89% | 258,262 | 7.06M |
| 483 | PASG | Passage Bio, Inc. | 17.87M | 1.83% | 27,563 | - |
| 484 | AKTX | Akari Therapeutics, Plc | 17.17M | -2.88% | 16,400 | - |
| 485 | NCEL | NewcelX Ltd. | 17.07M | -2.16% | 10,395 | - |
| 486 | SNSE | Sensei Biotherapeutics, Inc. | 16.95M | -2.85% | 55,593 | - |
| 487 | LEXX | Lexaria Bioscience Corp. | 16.56M | 3.31% | 110,729 | 368.00K |
| 488 | LPCN | Lipocine Inc. | 16.45M | 0.49% | 96,043 | 2.00M |
| 489 | QNCX | Quince Therapeutics, Inc. | 15.81M | -3.00% | 811,691 | - |
| 490 | CTXR | Citius Pharmaceuticals, Inc. | 15.26M | -5.65% | 411,560 | 5.61M |
| 491 | GTBP | GT Biopharma, Inc. | 15.07M | -1.69% | 1,047,433 | - |
| 492 | MLEC | Moolec Science SA | 14.92M | 0.42% | 9,114 | 7.83M |
| 493 | HIND | Vyome Holdings, Inc. | 14.81M | -3.65% | 9,821 | 152.72K |
| 494 | CALC | CalciMedica, Inc. | 14.33M | -5.01% | 242,360 | - |
| 495 | INAB | IN8bio, Inc. | 14.28M | 0.69% | 34,244 | - |
| 496 | BLRX | BioLineRx Ltd. | 14.19M | -1.51% | 7,883 | 1.40M |
| 497 | OSRH | OSR Holdings, Inc. | 14.13M | -0.12% | 816,340 | 2.63M |
| 498 | COCP | Cocrystal Pharma, Inc. | 14.06M | 0.99% | 65,530 | 225.00K |
| 499 | GDTC | CytoMed Therapeutics Limited | 13.45M | -1.18% | 3,554 | 669.28K |
| 500 | JSPR | Jasper Therapeutics, Inc. | 13.05M | -0.43% | 407,272 | - |